# Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung Cancer

> **NCT07698054** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 130 (estimated)

## Conditions studied

- SCLC, Extensive Stage
- Bayesian
- Metronomic Chemotherapy

## Interventions

- **DRUG:** Toripalimab; Etoposide

## Key facts

- **NCT ID:** NCT07698054
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2030-01-01
- **Final completion:** 2030-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698054, "Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*